Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matthew Byun

Fluocinolone Acetonide (0.19 Mg) Intravitreal Implant Reduces Treatment Burden and Improves Practice Resource Utilisation for Patients With Diabetic Macular Oedema

BMJ Open Ophthalmology

Ophthalmology

2020

English

Related publications

Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema

European Ophthalmic Review

2015

English

Fluocinolone Acetonide Intravitreal Implant (Retisert® ) in the Treatment of Sight Threatening Macular Oedema of Juvenile Idiopathic Arthritis-Related Uveitis

English

Three-Year Results From the Retro-Ideal Study: Real-World Data From Diabetic Macular Edema (DME) Patients Treated With ILUVIEN® (0.19 Mg Fluocinolone Acetonide Implant)

European Journal of Ophthalmology

Medicine

Ophthalmology

2019

English

Outcomes in Diabetic Macular Edema Switched Directly or After a Dexamethasone Implant to a Fluocinolone Acetonide Intravitreal Implant Following Anti-Vegf Treatment

English

Clinical Evaluation of Intravitreal Triamcinolone Acetonide in Diabetic Macular Oedema

Scholars Journal of Applied Medical Sciences

2016

English

Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients With Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience

Ophthalmology and Therapy

Ophthalmology

2019

English

Efficacy and Safety of Sustained-Delivery Fluocinolone Acetonide Intravitreal Implant in Patients With Chronic Diabetic Macular Edema Insufficiently Responsive to Available Therapies: A Real-Life Study

Clinical Ophthalmology

Ophthalmology

2016

English

Accidental Intralenticular Injection of Dexametasone Intravitreal Implant During the Treatment of Refractory Diabetic Macular Oedema

Oftalmologicheskii Zhurnal

Ophthalmology

2018

English

Change in Choroidal Volume After Dexamethasone Intravitreal Implant in Eyes With Diabetic Macular Oedema

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matthew Byun

Fluocinolone Acetonide (0.19 Mg) Intravitreal Implant Reduces Treatment Burden and Improves Practice Resource Utilisation for Patients With Diabetic Macular Oedema

Related publications

Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema

Fluocinolone Acetonide Intravitreal Implant (Retisert® ) in the Treatment of Sight Threatening Macular Oedema of Juvenile Idiopathic Arthritis-Related Uveitis

Three-Year Results From the Retro-Ideal Study: Real-World Data From Diabetic Macular Edema (DME) Patients Treated With ILUVIEN® (0.19 Mg Fluocinolone Acetonide Implant)

Outcomes in Diabetic Macular Edema Switched Directly or After a Dexamethasone Implant to a Fluocinolone Acetonide Intravitreal Implant Following Anti-Vegf Treatment

Clinical Evaluation of Intravitreal Triamcinolone Acetonide in Diabetic Macular Oedema

Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients With Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience

Efficacy and Safety of Sustained-Delivery Fluocinolone Acetonide Intravitreal Implant in Patients With Chronic Diabetic Macular Edema Insufficiently Responsive to Available Therapies: A Real-Life Study

Accidental Intralenticular Injection of Dexametasone Intravitreal Implant During the Treatment of Refractory Diabetic Macular Oedema

Change in Choroidal Volume After Dexamethasone Intravitreal Implant in Eyes With Diabetic Macular Oedema